Badische Presse

NYSE - LSE

RBGPF	-4.86%	66	$
BTI	-1.42%	59.8	$
GSK	-0.82%	51.27	$
BP	-1.98%	44.34	$
RIO	-1.55%	95.37	$
NGG	-0.56%	79.527	$
BCE	0.16%	21.715	$
AZN	-8.02%	157.05	$
BCC	5.18%	80.55	$
JRI	-0.93%	12.84	$
CMSD	-0.2%	22.065	$
CMSC	-0.14%	21.81	$
VOD	-1.12%	15.605	$
RYCEF	3.94%	20.3	$
RELX	1.58%	35.99	$

Featured

Iran denies negotiating with US, drawing Trump backlash

Iran denied any negotiations were taking place with the United States on Monday, sparking an angry backlash from President Donald Trump, who said he would keep up pressure on Tehran until there was a "Deal, or Total surrender".

'Spider-Man' breaks record for domestic box office debut

"Spider-Man: Brand New Day" had the biggest debut weekend of all time at the domestic box office, updated figures for the United States and Canada showed Monday.

Last news

Credit Suisse chief quits over Covid rules breach

The chairman of Credit Suisse resigned Monday over Covid quarantine violations, leaving the bank's new risk committee chief holding the reins and tasked with trying to stabilise the scandal-hit institution.

European stocks rise tracking big corporate news, China growth

European stock markets climbed on Monday as China's unexpectedly muted growth slowdown and optimism over the impact of the Omicron coronavirus variant boosted investor confidence.

Canada health authority approves Pfizer's anti-Covid pill

Canada's health authority said Monday it has approved Pfizer's anti-Covid pill, Paxlovid, for adults at high risk of progressing to serious disease.

Covid-flu joint booster jab possible late 2023: Moderna

Moderna aims to roll out a combined Covid-flu-RSV booster vaccine in late 2023, the US pharmaceutical firm said Monday, hoping a joint jab would encourage people to get an annual shot.

Badische Presse - Economy (English)